These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 237075)

  • 1. Thin layer chromatography-fluorimetic estimation of tolamolol in human plasma.
    Stopher DA
    J Pharm Pharmacol; 1975 Feb; 27(2):133-4. PubMed ID: 237075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency (author's transl)].
    Balant L; Gorgia A; Marmy A; Tschopp JM
    Nephrologie; 1980; 1(4):177-82. PubMed ID: 6895408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorimetric determination of atenolol in plasma and urine by direct evaluation of thin-layer chromatograms.
    Schäfer M; Mutschler E
    J Chromatogr; 1979 Feb; 169():477-81. PubMed ID: 536437
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacological studies with tolamolol in man.
    Faulkner JK; Stopher DA; Walden R
    Br J Clin Pharmacol; 1975 Oct; 2(5):423-8. PubMed ID: 786354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodensitometric determination of nadolol in plasma and urine.
    Schäfer-Korting M; Mutschler E
    J Chromatogr; 1982 Jul; 230(2):461-5. PubMed ID: 7107792
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantitative determination of tertatolol and its hydroxylated metabolite in human plasma and urine by gas chromatography-mass spectrometry.
    Efthymiopoulos C; Staveris S; Weber F; Koffel JC; Jung L
    J Chromatogr; 1987 Oct; 421(2):360-6. PubMed ID: 2892852
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of betaxolol in plasma by high-performance liquid chromatography with fluorescence detection.
    Canal M; Flouvat B
    J Chromatogr; 1985 Jul; 342(1):212-5. PubMed ID: 2864353
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of tertatolol enantiomers in biological fluids by high-performance liquid chromatography.
    Lave T; Efthymiopoulos C; Koffel JC; Jung L
    J Chromatogr; 1991 Dec; 572(1-2):203-10. PubMed ID: 1687817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of bucindolol and its major metabolites in plasma by capillary gas chromatography-mass spectrometry.
    Bartek MJ; Kerns EH; Gammans RE; Gallo DG
    J Chromatogr; 1986 Apr; 377():183-94. PubMed ID: 3711207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.
    Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bunitrolol metabolism and its inhibition by cimetidine.
    Ishida R; Fujita S; Suzuki T
    J Pharm Pharmacol; 1988 Jan; 40(1):64-5. PubMed ID: 2896780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol determination by high-performance liquid chromatography and fluorescence detection.
    Yee YG; Rubin P; Blaschke TF
    J Chromatogr; 1979 Apr; 171():357-62. PubMed ID: 546856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of nadolol in serum by reversed-phase high-performance liquid chromatography with fluorometric detection.
    Moncrieff J
    J Chromatogr; 1985 Jul; 342(1):206-11. PubMed ID: 4044751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clearance concept applied to pharmacokinetics: 1. Application for the study of tolamolol (beta-blocking agent) in healthy volunteers (author's transl)].
    Balant L; Faulkner JK; Tozer TN
    Nephrologie; 1980; 1(4):172-6. PubMed ID: 6895407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid analysis for metabolites of 11C-labelled drugs: fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog.
    Jones HA; Rhodes CG; Law MP; Becket JM; Clark JC; Boobis AR; Taylor GW
    J Chromatogr; 1991 Oct; 570(2):361-70. PubMed ID: 1686775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorptive thin film microextraction followed by direct solid state spectrofluorimetry: A simple, rapid and sensitive method for determination of carvedilol in human plasma.
    Karimi S; Talebpour Z; Adib N
    Anal Chim Acta; 2016 Jun; 924():45-52. PubMed ID: 27181643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thin-layer chromatographic analysis of some beta-blocking drugs in plasma.
    Witek A; Przyborowski L
    Acta Pol Pharm; 1997; 54(3):183-6. PubMed ID: 9511444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the beta-adrenoceptor blocking drug B24/76 in serum by high-performance liquid chromatography with fluorimetric detection after pre-column dansylation.
    Zschiesche M; Baumann A
    J Chromatogr; 1989 Mar; 488(2):482-6. PubMed ID: 2568366
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism of carvedilol in man.
    Neugebauer G; Neubert P
    Eur J Drug Metab Pharmacokinet; 1991; 16(4):257-60. PubMed ID: 1823868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.